 |
인쇄하기
취소
|
Korea Exchange OKs Myungmoon’s plan to join main bourse
Korea's bourse operator Korea Exchange says that Myungmoon Pharm’s stocks will be listed in the KOSPI from July 10.
With its public listing in main bourse, the company’s fresh aim is to solidify its position overseas and widen research and development in the life sciences industry.
To that end, Myungmoon is currently focusing on putting out more fresh medicines on the local market, such a...
With its public listing in main bourse, the company’s fresh aim is to solidify its position overseas and widen research and development in the life sciences industry.
To that end, Myungmoon is currently focusing on putting out more fresh medicines on the local market, such a...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.